Sudarshan Sukhani of s2analytics.com advises to buy Glenmark Pharma at current levels.
Sukhani told CNBC-TV18, “Yes there is a trade in Glenmark Pharma. It is a buying opportunity. It was in our list in the morning and there is a small correction, that correction is over and you have referred correctly, there were two days on which it saw very impressive rallies and today is the third day.”
He further added, “I would be a buyer here. It is not a day trade because Glenmark is not that sort of a stock but if you buy now and hold I think it is a very sensible idea for a few days or weeks.”
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!